News
Sign up for the Proefdiervrij Venture Challenge 2026
Animal-free science is the science of the future. Unfortunately, promising animal-free research models often fail in the Valley of Death: the infamous gap between scientific research and practical application.VivArt-X secures €3 million to accelerate regenerative breast reconstruction innovation
VivArt-X has secured €3 million in funding to fast-track the development of its regenerative biomaterials for breast tissue reconstruction.These are the Venture Challenge Winter 2025/26 MedTech teams!
Six teams have started the Venture Challenge Winter 2025/26 MedTech teams! These starting MedTech entrepreneurs will learn everything about building and pitching a business plan.
Cristal Therapeutics and Curapath strengthen collaboration around CliCr® bioconjugation platform
LS@W alumnus Cristal Therapeutics has announced a co-exclusive licensing agreement with Curapath for the CliCr® bioconjugation platform, marking an important next step in the development of advanced drug delivery technologiAlumni News: Cristal Therapeutics signs co-exclusive licence agreement with Curapath to expand CliCr® platform
LS@W alumnus Cristal Therapeutics has reached an important milestone in the development and adoption of its CliCr® bioconjugation platform.
BioVenture Builder Now Open for Applications
A new long-term support programme for early-stage biotech ventures in the Netherlands
Alumni News: Saturn Pelvic Health wins Innovation Promise 2025
Venture Challenge Spring 2023 alumnus Saturn Pelvic Health has been named the Innovation Promise of 2025 in the Health & Nutrition category of the Dutch Chamber of Commerce Innovation Top 100.
Alumni News: Sherwood Pharmaceuticals wins Investor Forum at Dutch Life Sciences Conference 2025
We are proud to share that Sherwood Pharmaceuticals — alumni of the Drug Repurposing Venture Challenge 2025 — has won the Investor Forum Award at the Dutch Life Sciences Conference. Congratulations to Dr. Karen E.
Myriagon wins Venture Challenge Fall 2025!
The winner of the Venture Challenge Fall 2025 was announced today at the Dutch Life Sciences Conference.